Literature DB >> 15517132

[Intra-articular therapy with autologous interleukin-1 receptor antagonist in osteoarthritis. Innovation or quackery?].

D Stengel1, A Ekkernkamp, M Wich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15517132     DOI： 10.1007/s00113-004-0885-9

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN： 0177-5537            Impact factor:   1.000


× No keyword cloud information.
  7 in total

1.  Neurophysiologic changes in lumbar nerve root inflammation in the rat after treatment with cytokine inhibitors. Evidence for a role of interleukin-1.

Authors:  P Wehling; S J Cleveland; K Heininger; K P Schulitz; J Reinecke; C H Evans
Journal:  Spine (Phila Pa 1976)       Date:  1996-04-15       Impact factor: 3.468

2.  The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils.

Authors:  J K Jenkins; M Malyak; W P Arend
Journal:  Lymphokine Cytokine Res       Date:  1994-02

3.  Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis.

Authors:  G S Firestein; D L Boyle; C Yu; M M Paine; T D Whisenand; N J Zvaifler; W P Arend
Journal:  Arthritis Rheum       Date:  1994-05

Review 4.  The interleukin-1 system and female reproduction.

Authors:  N Gérard; M Caillaud; A Martoriati; G Goudet; A-C Lalmanach
Journal:  J Endocrinol       Date:  2004-02       Impact factor: 4.286

5.  Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.

Authors:  M Malyak; M F Smith; A A Abel; W P Arend
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

6.  The production of anti-inflammatory cytokines in whole blood by physico-chemical induction.

Authors:  H Meijer; J Reinecke; C Becker; G Tholen; P Wehling
Journal:  Inflamm Res       Date:  2003-10       Impact factor: 4.575

7.  Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.

Authors:  R Horai; S Saijo; H Tanioka; S Nakae; K Sudo; A Okahara; T Ikuse; M Asano; Y Iwakura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307
  7 in total
  1 in total

1.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.